We found that miR-613 is the target of MALAT1 and that it can bind to the 3′-UTR of COMMD8. MALAT1 upregulated the level of COMMD8 by competitively targeting miR-613, thus playing a carcinogenic role in NSCLC (52). Here, MALAT1 is linked to non-small cell lung carcinoma.